ASS1 and cancer: In agreement with other study showing reexpression of ASS1 in cancer tissues after treatment with arginine depletion enzyme ADI-PEG20 [74], on the basis of which cancer cells might acquire treatment resistance, we also observed the emergence of ASS1 in cancer cells lacking basal ASS1 upon being deprived of arginine in culture media.